Company / Operating Income per Share
Idexx Laboratories Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$16.67
FY2025
5-year range
$10.63 / $16.67
FY2021-FY2025
Trend
+22.6%
vs FY2024
Sector context
#12 of 149
Health Care
What the data says
Among 149 Health Care companies, Idexx Laboratories is in the top 8% for operating income per share. Operating Income per Share has increased for 3 consecutive years, from $10.63 in FY2022 to $16.67 in FY2025.
Based on SEC 10-K filings.
16.67 in FY2025 with a 5-year CAGR of +15.4%. Top quartile in the Health Care sector.
Improved from $13.24 to $16.67 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +16.2%
- 5-Year CAGR
- +15.4%
- 10-Year CAGR
- -
Sector benchmark
+287.7% above sector average
Key checks
Key Insights
- Idexx Laboratories's operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 22.6% year-over-year.
- Ranks #12 out of 149 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.67 | +22.6% |
| FY2024 | $13.59 | +2.7% |
| FY2023 | $13.24 | +24.5% |
| FY2022 | $10.63 | -2.6% |
| FY2021 | $10.91 | +34.2% |
| FY2020 | $8.13 | +26.6% |
| FY2019 | $6.42 | +13.8% |
| FY2018 | $5.64 | +27.9% |
| FY2017 | $4.41 | +27.8% |
| FY2016 | $3.45 | +24.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026